Drug intelligence / Profile preview

Jindbi Fang granules

Development stage
Unknown
Lead developer
Longhua Hospital Shanghai University of Traditional Chinese Medicine
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Jindbi Fang granules is a Traditional Chinese Medicine (TCM) formula developed by Longhua Hospital affiliated to Shanghai University of Traditional Chinese Medicine for the treatment of cervical spondylotic myelopathy (CSM), specifically the "Bi-syndrome" type. The formula is designed to nourish the liver and kidney, relax tendons, and activate collaterals, addressing the underlying TCM pathology of tendon and bone degeneration. It is currently being investigated in a randomized, parallel-group clinical trial (ChiCTR2500113740) to evaluate its efficacy and safety in adults with mild to moderate CSM, with the goal of improving neurological symptoms and functional outcomes compared to placebo.

Other names
Jindbi decoctionJinbi Fang granulesJinbi decoction
02

Targets

PPARG (Peroxisome proliferator-activated receptor gamma)STAT3 (Signal Transducer and Activator of Transcription 3)NF-κBKEAP1 (Kelch-like ECH-associated protein 1)AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)NLRP3 (Nod-like receptor family pyrin domain-containing protein 3)

Beyond the preview

Go deeper on Jindbi Fang granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jindbi Fang granules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call